Clinical utility of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Lim, Yoojoo [1 ]
Kim, Sheehyun [5 ]
Kang, Jun-Kyu [1 ,2 ]
Kim, Hwang-Phil [2 ,6 ]
Roh, Hanseong [1 ]
Kim, Su Yeon [1 ]
Lee, Dongin [3 ]
Bang, Duhee [1 ,3 ]
Jeong, Seung-Yong [4 ]
Park, Kyu Joo [4 ]
Han, Sae-Won [5 ,6 ]
Kim, Tae-You [1 ,5 ,6 ]
机构：
[1] IMBdx Inc, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Genom Med, Seoul, South Korea
[3] Yonsei Univ, Dept Chem, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea
[5] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO41-4
引用
下载
收藏
页码：S507 / S507
页数：1
相关论文
共 50 条
  • [1] Longitudinal monitoring of circulating tumor DNA (ctDNA) during disease course of metastatic colorectal cancer (mCRC)
    Lim, Yoojoo
    Kim, Sheehyun
    Kang, Jun-Kyu
    Kim, Hwang-Phill
    Roh, Hanseong
    Kim, Su Yeon
    Lee, Dongin
    Bang, Duhee
    Jeong, Seung-Yong
    Park, Kyu Joo
    Han, Sae-Won
    Kim, Tae-You
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] Predictors for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Loree, Jonathan M.
    Davis, Jennifer S.
    Lam, Michael
    Morris, Van Karlyle
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Kee, Bryan K.
    Fogelman, David R.
    Sanchez, Eduardo Vilar
    Shureiqi, Imad
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Lanman, Richard B.
    Talasaz, AmirAli
    Janku, Filip
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Parikh, Aparna Raj
    Van Seventer, Emily E.
    Jia, Jingquan
    Loree, Jonathan M.
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Overman, Michael J.
    Raymond, Victoria M.
    Lanman, Richard B.
    Talasaz, AmirAli
    Strickler, John H.
    Corcoran, Ryan Bruce
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Clinical utility of serial circulating tumor DNA (ctDNA) to identify acquired resistance to anti-EGFR antibodies in metastatic colorectal cancer (mCRC).
    Loree, Jonathan M.
    Bubie, Adrian
    Eluri, Madhulika
    Parseghian, Christine Megerdichian
    Overman, Michael J.
    Zhang, Nicole
    Drusbosky, Leylah
    Kopetz, Scott
    Raghav, Kanwal Pratap Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 158 - 158
  • [5] Clinical utility of circulating tumor DNA (ctDNA) in advanced and metastatic breast cancer
    Austin, Laura K.
    Jaslow, Rebecca
    Avery, Tiffany
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
  • [6] Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Ohta, Takashi
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Hata, Masayuki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Comprehensive landscape of gene amplifications (amps) in tissue and circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Raghav, Kanwal Pratap Singh
    Yaeger, Rona
    Loree, Jonathan M.
    Dasari, Arvind
    Morris, Van K.
    Kee, Bryan K.
    Raymond, Victoria M.
    Nagy, Rebecca J.
    Lanman, Richard B.
    Strickler, John H.
    Corcoran, Ryan Bruce
    Overman, Michael J.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal Cancer
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    ONCOLOGIST, 2018, 23 (11): : 1310 - 1318
  • [9] Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy
    Ghidini, M.
    Hahne, J. C.
    Senti, C.
    Tomasello, G.
    Ratti, M.
    Heide, T.
    Garrone, O.
    Cortellini, A.
    Passalacqua, R.
    Valeri, N.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [10] Circulating tumor DNA (ctDNA) as an early marker to monitor clinical benefit of regorafenib and TAS-102 in patients with metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Lam, Michael
    Marie, Preeti Kanikarla
    Raghav, Kanwal Pratap Singh
    Morris, Van Karlyle
    Brown, Hiromi
    Windham, Justin
    Duose, Dzifa Yawa
    Overman, Michael J.
    Sanchez, Eduardo Vilar
    Wistuba, Ignacio Ivan
    Kipp, Peter
    Janku, Filip
    Sinha, Sudhir
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345